bmp Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk.
BiotechConsumerHealthtechMedical DevicesNew MaterialsWellness & FitnessHalle (Saale), DE
Pierre Tangermann(CEO)inDr. Mirko Buchholz(Chief Scientific Officer)Dr. Nadine Taudte(Head of Biological Research)Jean-Marie Bryl(Head of Communications & Public Affairs)in
Co-investorsBiotech Investments S.R.OCompanisto
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.